UNSPSC 51182412: Tribasic calcium phosphates

This classification denotes a form of tricalcium phosphate are used as bioceramic bone replacement material; see also records for alpha-tricalcium phosphate, beta-tricalcium phosphate, calcium phosphate; apatitic tricalcium phosphate Ca9(HPO4)(PO4)5(OH) is the calcium orthophosphate leading to beta tricalcium phosphate Ca3(PO4)2 (b-TCP), with the molecular formula 5CA.3O4P.HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 91D9GV0Z28.

European Medicines Agency schedules tribasic calcium phosphatein its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB34727. The term tribasic calcium phosphate is Homeopathic Pharmacopoeia of the United States designation.

UNSPSC 51182412 Tribasic calcium phosphates, a Commodity code, reflects purchases of calcium phosphate compounds used primarily as nutritional supplements, food additives, and pharmaceutical ingredients by state and local health departments, school districts, and correctional facilities. State and local governments procure these materials for inmate and student nutrition programs, public health initiatives, and institutional food service operations where calcium fortification or phosphate supplementation is required by dietary or medical protocols.

The source provides no recent state and local contract opportunities tagged to this code, limiting visibility into current issuing-body concentration, geographic spread, or representative solicitation activity. This silence may reflect the commodity's specialized use within institutional procurement channels or its primary sourcing through cooperative purchasing agreements rather than individual agency RFPs and RFQs.